452 related articles for article (PubMed ID: 3754001)
1. Parallel postnatal development of choline acetyltransferase activity and muscarinic acetylcholine receptors in the rat olfactory bulb.
Large TH; Lambert MP; Gremillion MA; Klein WL
J Neurochem; 1986 Mar; 46(3):671-80. PubMed ID: 3754001
[TBL] [Abstract][Full Text] [Related]
2. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
3. Developmental profiles of various cholinergic markers in the rat main olfactory bulb using quantitative autoradiography.
Le Jeune H; Aubert I; Jourdan F; Quirion R
J Comp Neurol; 1996 Sep; 373(3):433-50. PubMed ID: 8889937
[TBL] [Abstract][Full Text] [Related]
4. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.
Galper JB; Dziekan LC; O'Hara DS; Smith TW
J Biol Chem; 1982 Sep; 257(17):10344-56. PubMed ID: 7107608
[TBL] [Abstract][Full Text] [Related]
5. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
6. Effects of aging and cholinergic deafferentation on putative muscarinic cholinergic receptor subtypes in rat cerebral cortex.
Norman AB; Blaker SN; Thal L; Creese I
Neurosci Lett; 1986 Oct; 70(2):289-94. PubMed ID: 3774231
[TBL] [Abstract][Full Text] [Related]
7. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
8. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
Baker SP; Posner P
Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
[TBL] [Abstract][Full Text] [Related]
9. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
10. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens.
De Belleroche J; Kilpatrick IC; Birdsall NJ; Hulme EC
Brain Res; 1982 Feb; 234(2):327-37. PubMed ID: 7059834
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
13. Evidence for developmental synaptic regression of cholinergic afferents to the rat main olfactory bulb.
Rea MA; Nurnberger JI
Brain Res; 1986 Jan; 389(1-2):233-7. PubMed ID: 3948009
[TBL] [Abstract][Full Text] [Related]
14. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain.
Aubert I; Cécyre D; Gauthier S; Quirion R
J Comp Neurol; 1996 May; 369(1):31-55. PubMed ID: 8723701
[TBL] [Abstract][Full Text] [Related]
15. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ
J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1986 May; 237(2):577-82. PubMed ID: 3009794
[TBL] [Abstract][Full Text] [Related]
17. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
18. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
Watson M; Yamamura HI; Roeske WR
Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111
[TBL] [Abstract][Full Text] [Related]
19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
Xu J; Chuang DM
J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]